“By invoking emergency power to impose an across-the-board tariff on imports from China that the statute does not authorize, President Trump has misused that power, usurped Congress’s right to control ...

Ms. Whitaker is an accomplished C-suite leader, most recently as Chair and CEO of Aerami Therapeutics Holdings Inc. During her executive career she has held senior leadership roles at GlaxoSmithKline ...

Erian, among others, are reacting to President Donald Trump's tariff announcement.

DIV is a multi-royalty corporation, engaged in the business of acquiring top-line royalties from well-managed multi-location businesses and franchisors in North America. DIV’s objective is to acquire ...

Trump's tariffs could hit Amazon and Meta hard because of their reliance on Chinese advertisers. Here's how other companies ...

Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, announced today that its Board of Directors (the “Board”) has ...

MIAMI, April 03, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) announced that it will report results for the second fiscal quarter ended March 31, 2025 ...

Vaidio’s winning 9th generation platform features powerful agentic intelligence and GenAI capabilities. A new camera auto-configuration agent uses the latest vision language models (VLMs) to automate ...

Trump's tariffs announcement has companies scrambling as their costs increase. Here's which companies have hinted at raising ...

With 93% of team members agreeing that Credit Acceptance is a great place to work, the Company is continuously ranked as one of the best places to work. We remain committed to fostering an environment ...

MIAMI, April 03, 2025 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) announced that it will report results for the second fiscal quarter ended March 31, 2025 on ...

Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10 million ...